PL2407036T3 - Sposób stymulowania integralności bariery jelitowej po nienaturalnym porodzie - Google Patents
Sposób stymulowania integralności bariery jelitowej po nienaturalnym porodzieInfo
- Publication number
- PL2407036T3 PL2407036T3 PL11178047T PL11178047T PL2407036T3 PL 2407036 T3 PL2407036 T3 PL 2407036T3 PL 11178047 T PL11178047 T PL 11178047T PL 11178047 T PL11178047 T PL 11178047T PL 2407036 T3 PL2407036 T3 PL 2407036T3
- Authority
- PL
- Poland
- Prior art keywords
- intestinal barrier
- barrier integrity
- stimulating intestinal
- natural birth
- birth
- Prior art date
Links
- 210000005027 intestinal barrier Anatomy 0.000 title 1
- 230000007358 intestinal barrier function Effects 0.000 title 1
- 230000004936 stimulating effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- A23C9/203—Dietetic milk products not covered by groups A23C9/12 - A23C9/18 containing bifidus-active substances, e.g. lactulose; containing oligosaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- A23C9/206—Colostrum; Human milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/143—Fermentum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/151—Johnsonii
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/157—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/165—Paracasei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/173—Reuteri
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/187—Zeae
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/513—Adolescentes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/515—Animalis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/517—Bifidum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/519—Breve
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/521—Catenulatum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/527—Gallicum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/529—Infantis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/535—Pseudocatenulatum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/537—Thermacidophilum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/732—Pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/734—Alginic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05023029A EP1776877A1 (en) | 2005-10-21 | 2005-10-21 | Method for stimulating the intestinal flora |
EP06799538A EP1940247B1 (en) | 2005-10-21 | 2006-10-06 | Method for stimulating intestinal barrier integrity after non-natural birth |
EP09161674.8A EP2105055B1 (en) | 2005-10-21 | 2006-10-06 | Method for stimulating intestinal barrier integrity after birth by caesarean section |
EP11178047.4A EP2407036B1 (en) | 2005-10-21 | 2006-10-06 | Method for stimulating intestinal barrier integrity after non-natural birth |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2407036T3 true PL2407036T3 (pl) | 2016-05-31 |
Family
ID=35809614
Family Applications (8)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06799538T PL1940247T3 (pl) | 2005-10-21 | 2006-10-06 | Sposób stymulowania integralności bariery jelitowej po nienaturalnym porodzie |
PL11178047T PL2407036T3 (pl) | 2005-10-21 | 2006-10-06 | Sposób stymulowania integralności bariery jelitowej po nienaturalnym porodzie |
PL09161674T PL2105055T3 (pl) | 2005-10-21 | 2006-10-06 | Sposób stymulowania integralności bariery jelitowej po porodzie przez cesarskie cięcie |
PL06799537T PL1940246T3 (pl) | 2005-10-21 | 2006-10-06 | Zapobieganie chorobom u dzieci narodzonych z cesarskiego cięcia |
PL09011197T PL2140771T3 (pl) | 2005-10-21 | 2006-10-20 | Metoda stymulacji flory jelitowej u niemowląt urodzonych przez cesarskie cięcie |
PL13171226T PL2638812T3 (pl) | 2005-10-21 | 2006-10-20 | Kompozycja do stymulacji flory jelitowej u niemowląt urodzonych przez cesarskie cięcie |
PL06806443T PL1940250T3 (pl) | 2005-10-21 | 2006-10-20 | Sposób stymulowania flory jelitowej |
PL17205437T PL3326634T3 (pl) | 2005-10-21 | 2006-10-20 | Kompozycja do zastosowania w stymulacji flory jelitowej u niemowląt urodzonych przez cesarskie cięcie |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06799538T PL1940247T3 (pl) | 2005-10-21 | 2006-10-06 | Sposób stymulowania integralności bariery jelitowej po nienaturalnym porodzie |
Family Applications After (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL09161674T PL2105055T3 (pl) | 2005-10-21 | 2006-10-06 | Sposób stymulowania integralności bariery jelitowej po porodzie przez cesarskie cięcie |
PL06799537T PL1940246T3 (pl) | 2005-10-21 | 2006-10-06 | Zapobieganie chorobom u dzieci narodzonych z cesarskiego cięcia |
PL09011197T PL2140771T3 (pl) | 2005-10-21 | 2006-10-20 | Metoda stymulacji flory jelitowej u niemowląt urodzonych przez cesarskie cięcie |
PL13171226T PL2638812T3 (pl) | 2005-10-21 | 2006-10-20 | Kompozycja do stymulacji flory jelitowej u niemowląt urodzonych przez cesarskie cięcie |
PL06806443T PL1940250T3 (pl) | 2005-10-21 | 2006-10-20 | Sposób stymulowania flory jelitowej |
PL17205437T PL3326634T3 (pl) | 2005-10-21 | 2006-10-20 | Kompozycja do zastosowania w stymulacji flory jelitowej u niemowląt urodzonych przez cesarskie cięcie |
Country Status (21)
Country | Link |
---|---|
US (8) | US8715769B2 (pl) |
EP (11) | EP1776877A1 (pl) |
JP (1) | JP2009512686A (pl) |
CN (9) | CN103816173B (pl) |
AR (4) | AR058132A1 (pl) |
AT (4) | ATE432620T1 (pl) |
AU (3) | AU2006304993A1 (pl) |
BR (3) | BRPI0617645A2 (pl) |
CA (3) | CA2626615C (pl) |
DE (4) | DE602006008817D1 (pl) |
DK (7) | DK1940247T3 (pl) |
ES (8) | ES2560291T3 (pl) |
HU (2) | HUE028348T2 (pl) |
MY (4) | MY145999A (pl) |
NZ (3) | NZ567579A (pl) |
PL (8) | PL1940247T3 (pl) |
PT (8) | PT2407036E (pl) |
RU (6) | RU2437581C2 (pl) |
SG (2) | SG10201503970XA (pl) |
TR (1) | TR201808654T4 (pl) |
WO (4) | WO2007046698A1 (pl) |
Families Citing this family (119)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006012536A2 (en) | 2004-07-22 | 2006-02-02 | Ritter Andrew J | Methods and compositions for treating lactose intolerance |
EP1776877A1 (en) * | 2005-10-21 | 2007-04-25 | N.V. Nutricia | Method for stimulating the intestinal flora |
ATE509624T1 (de) | 2005-12-23 | 2011-06-15 | Nutricia Nv | Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz |
US20080254166A1 (en) * | 2007-01-25 | 2008-10-16 | Potter Susan M | Food Additives Containing Combinations of Prebiotics and Probiotics |
EP1974743A1 (en) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics to Improve Gut Microbiota |
WO2008153377A1 (en) * | 2007-06-15 | 2008-12-18 | N.V. Nutricia | Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide |
CA2687639A1 (en) * | 2007-06-25 | 2008-12-31 | Dsm Ip Assets B.V. | Novel prebiotics |
EP2200443B2 (en) * | 2007-09-17 | 2021-06-30 | Cornell University | Branched chain fatty acids for prevention or treatment of gastrointestinal disorders |
ATE536105T1 (de) | 2007-09-17 | 2011-12-15 | Nutricia Nv | Ernährungsformulierung mit hohem energetischen gehalt |
WO2009047754A2 (en) † | 2007-10-09 | 2009-04-16 | Enzymotec Ltd. | Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation |
WO2009067000A1 (en) * | 2007-11-20 | 2009-05-28 | N.V. Nutricia | Composition with synbiotics |
EP2072052A1 (en) * | 2007-12-17 | 2009-06-24 | Nestec S.A. | Prevention of opportunistic infections in immune-compromised subjects |
WO2009082216A1 (en) * | 2007-12-21 | 2009-07-02 | N.V. Nutricia | Use of sphingomyelin and non-digestible carbohydrates for improving intestinal microbiota |
EP2252370B1 (en) * | 2008-02-08 | 2018-03-14 | N.V. Nutricia | Use of lipid-rich nutrition for the treatment of post-operative ileus |
WO2009102193A1 (en) * | 2008-02-12 | 2009-08-20 | N.V. Nutricia | A composition comprising bifidobacterium infantis and fructo- and galacto-oligosaccharides for the prevention of intestinal discomfort in infants |
UA100551C2 (en) | 2008-03-14 | 2013-01-10 | Нестек С.А. | Synbiotic mixture |
EP2143341A1 (en) * | 2008-07-08 | 2010-01-13 | Nestec S.A. | Nutritional Composition Containing Oligosaccharide Mixture |
WO2009148315A1 (en) * | 2008-06-06 | 2009-12-10 | N.V. Nutricia | Method for preventing corticosteroid usage |
EP2130440A1 (en) * | 2008-06-06 | 2009-12-09 | N.V. Nutricia | Inhibiting E. sakazakii growth |
WO2009151315A1 (en) * | 2008-06-13 | 2009-12-17 | N.V. Nutricia | Nutritional composition for infants delivered via caesarean section |
PL2285387T3 (pl) | 2008-06-13 | 2016-03-31 | Nutricia Nv | Odżywka do zapobiegania infekcjom |
WO2010002241A1 (en) * | 2008-06-30 | 2010-01-07 | N.V. Nutricia | Nutritional composition for infants delivered via caesarean section |
EP2147678A1 (en) * | 2008-07-21 | 2010-01-27 | Nestec S.A. | Probiotics to increase IgA secretion in infants born by caesarean section |
BRPI1008280A2 (pt) * | 2009-02-24 | 2015-08-25 | Ritter Pharmaceuticals Inc | Formulações prebióticas e métodos mde uso |
CN101861984B (zh) * | 2009-04-16 | 2012-05-23 | 罗晶 | 低聚糖魔芋米及其制备方法 |
ES2559008T3 (es) * | 2009-05-11 | 2016-02-10 | Nestec S.A. | Bifidobacterium longum NCC2705 no replicante y trastornos inmunitarios |
WO2011008086A1 (en) * | 2009-07-15 | 2011-01-20 | N.V. Nutricia | Mixture of non-digestible oligosaccharides for stimulating the immune system |
BR112012000859B1 (pt) * | 2009-07-15 | 2021-08-03 | N.V. Nutricia | Uso de 2'-fucosilactose na fabricação de uma composição enteral |
WO2011019641A2 (en) * | 2009-08-13 | 2011-02-17 | Nestec S.A. | Nutritional compositions including exogenous nucleotides |
FR2955774A1 (fr) | 2010-02-02 | 2011-08-05 | Aragan | Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation |
IT1398553B1 (it) * | 2010-03-08 | 2013-03-01 | Probiotical Spa | Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario. |
WO2011139621A1 (en) * | 2010-04-26 | 2011-11-10 | Nestec S.A. | Nutritional compositions and methods for weaning from parenteral nutrition to enteral nutrition |
EP2563372A4 (en) | 2010-04-28 | 2013-10-02 | Ritter Pharmaceuticals Inc | PREBIOTIC FORMULATIONS AND METHODS OF USE |
WO2011150949A1 (en) | 2010-06-04 | 2011-12-08 | N.V. Nutricia | Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins |
EP2575509A1 (en) * | 2010-06-04 | 2013-04-10 | N.V. Nutricia | Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins |
EP2593466B1 (en) | 2010-07-12 | 2018-05-30 | The Regents of The University of California | Bovine milk oligosaccharides |
US9011909B2 (en) | 2010-09-03 | 2015-04-21 | Wisconsin Pharmacal Company, Llc | Prebiotic suppositories |
WO2012044155A1 (en) | 2010-09-28 | 2012-04-05 | N.V. Nutricia | Fat composition for programming immune response |
EP2454948A1 (en) * | 2010-11-23 | 2012-05-23 | Nestec S.A. | Oligosaccharide mixture and food product comprising this mixture, especially infant formula |
EP2910132A1 (en) * | 2010-12-06 | 2015-08-26 | N.V. Nutricia | Fermented infant formula |
MY162776A (en) | 2010-12-29 | 2017-07-14 | Abbott Lab | Nutritional products including monoglycerides and fatty acids |
NZ612504A (en) | 2010-12-31 | 2015-02-27 | Abbott Lab | Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents |
US20120171166A1 (en) * | 2010-12-31 | 2012-07-05 | Abbott Laboratories | Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota |
EP3338784B1 (en) | 2010-12-31 | 2020-07-22 | Abbott Laboratories | Human milk oligosaccharides for modulating inflammation |
WO2012092160A2 (en) | 2010-12-31 | 2012-07-05 | Abbott Laboratories | Human milk oligosaccharides to promote growth of beneficial bacteria |
NZ613165A (en) | 2010-12-31 | 2015-02-27 | Abbott Lab | Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated fatty acids and uses thereof |
US9763970B2 (en) | 2010-12-31 | 2017-09-19 | Abbott Laboratories | Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection |
ES2708924T3 (es) | 2010-12-31 | 2019-04-12 | Abbott Lab | Procedimientos de uso de oligosacáridos de la leche humana para mejorar la salud respiratoria de las vías respiratorias |
US9539269B2 (en) | 2010-12-31 | 2017-01-10 | Abbott Laboratories | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides |
WO2012138698A1 (en) * | 2011-04-08 | 2012-10-11 | Ancora Pharmaceuticals Inc. | Synthesis of beta-mannuronic acid oligosaccharides |
GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
WO2013032674A1 (en) | 2011-08-29 | 2013-03-07 | Abbott Laboratories | Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
WO2013130773A2 (en) | 2012-02-29 | 2013-09-06 | Ethicon Endo-Surgery, Inc. | Compositions of microbiota and methods related thereto |
WO2013187755A1 (en) | 2012-06-14 | 2013-12-19 | N.V. Nutricia | Fermented infant formula with non digestible oligosaccharides |
ES2884223T3 (es) * | 2012-11-02 | 2021-12-10 | Nutricia Nv | Combinación de simbióticos para la mejora del cerebro |
CN103193896B (zh) * | 2013-03-12 | 2015-09-16 | 武汉纤浓生物科技有限公司 | 一种魔芋葡甘低聚糖的制备方法及其所采用的薄膜蒸发器 |
GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
US20160074422A1 (en) * | 2013-05-08 | 2016-03-17 | Northeastern University | Mucus strengthening formulations to alter mucus barrier properties |
EP3082828B1 (en) | 2013-11-15 | 2022-03-02 | Société des Produits Nestlé S.A. | Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by c-section |
MX2016006060A (es) * | 2013-11-15 | 2016-08-03 | Nestec Sa | Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños. |
US10357506B2 (en) | 2013-11-15 | 2019-07-23 | Nestec S.A. | Compositions for use in the prevention or treatment of URT infections in infants or young children at risk |
JP6448641B2 (ja) * | 2013-11-29 | 2019-01-09 | ガルデルマ・ソシエテ・アノニム | アトピー性皮膚炎の治療及び/又は予防のためのアベルメクチンファミリー又はミルベマイシンファミリーの化合物 |
RU2699981C2 (ru) * | 2014-08-18 | 2019-09-11 | Сосьете Де Продюи Нестле С.А. | Пребиотики для снижения риска развития ожирения в дальнейшей жизни |
ES2885851T3 (es) * | 2014-09-30 | 2021-12-15 | Nestle Sa | Composición nutricional para la utilización en la estimulación de la maduración del hígado |
BR112017008284A8 (pt) | 2014-10-24 | 2023-04-11 | Evolve Biosystems Inc | Bifidobactérias ativadas e métodos para uso das mesmas |
EP3212001A4 (en) | 2014-10-31 | 2018-04-25 | Whole Biome Inc. | Methods and compositions relating to microbial treatment and diagnosis of disorders |
CZ306548B6 (cs) * | 2014-12-04 | 2017-03-01 | Výzkumný ústav mlékárenský, s.r.o. | Probiotický přípravek sušený se zvlhčujícím efektem pro speciální aplikace |
EP3065748B1 (en) | 2014-12-23 | 2017-11-22 | 4D Pharma Research Limited | A bacteroides thetaiotaomicron strain and its use in reducing inflammation |
EP3193901B1 (en) | 2014-12-23 | 2018-04-04 | 4D Pharma Research Limited | Pirin polypeptide and immune modulation |
AU2016227595B2 (en) * | 2015-03-05 | 2020-08-27 | Société des Produits Nestlé S.A. | Compositions for use in the prevention or treatment of otitis or bronchitis in infants or young children |
SG11201707506WA (en) * | 2015-03-13 | 2017-10-30 | Evolve Biosystems Inc | Compositions that metabolize or sequester free sugar monomers and uses thereof |
US10793847B2 (en) | 2015-05-11 | 2020-10-06 | Mybiotics Pharma Ltd. | Systems and methods for growing a biofilm of probiotic bacteria on solid particles for colonization of bacteria in the gut |
EP3294308A4 (en) | 2015-05-14 | 2019-03-06 | University of Puerto Rico | PROCESS FOR RECOVERING THE BIOZOOSE OF NEWBORN |
KR101589466B1 (ko) * | 2015-05-21 | 2016-02-01 | 주식회사 쎌바이오텍 | 성장 촉진을 위한 비피도박테리움 롱굼 cbt bg7 균주 및 이를 포함하는 성장촉진용 기능성 식품 조성물 |
KR101589465B1 (ko) * | 2015-05-21 | 2016-02-01 | 주식회사 쎌바이오텍 | 성장 촉진을 위한 비피도박테리움 브레베 cbt br3 균주 및 이를 포함하는 성장촉진용 기능성 식품 조성물 |
CN106259952B (zh) * | 2015-06-01 | 2019-01-15 | 内蒙古伊利实业集团股份有限公司 | 含有核苷酸和膳食纤维的1-3岁幼儿配方奶粉及其制备方法 |
MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
AU2016278067B2 (en) | 2015-06-15 | 2022-09-22 | Cj Bioscience, Inc. | Compositions comprising bacterial strains |
SI3307288T1 (sl) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Spojine, ki vsebujejo bakterijske seve |
EA038405B1 (ru) | 2015-06-15 | 2021-08-24 | 4Д Фарма Рисёрч Лимитед | ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ШТАММЫ БАКТЕРИИ Bifidobacterium breve, ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ЗАБОЛЕВАНИЯ ИЛИ ПАТОЛОГИЧЕСКОГО СОСТОЯНИЯ, ОПОСРЕДОВАННОГО IL-17 ИЛИ Th17 |
MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
US20180085384A1 (en) * | 2015-06-23 | 2018-03-29 | Nestec S.A. | Nutritional compositions and infant formulas containing oligofructose for reducing the load of pathogenic bacteria in the guts of infants and young children |
WO2017043963A1 (en) | 2015-09-11 | 2017-03-16 | N.V. Nutricia | Kit of parts for stimulating microbiota health after non-natural birth |
WO2017043962A1 (en) * | 2015-09-11 | 2017-03-16 | N.V. Nutricia | Method for stimulating microbiota health after non-natural birth |
CN105176822B (zh) * | 2015-10-23 | 2019-01-11 | 广州康泽医疗科技有限公司 | 一种人类肠道益生菌的优化分离方法 |
GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
MD3209310T2 (ro) | 2015-11-20 | 2018-06-30 | 4D Pharma Res Ltd | Compoziții care conțin tulpini bacteriene |
GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
WO2017117142A1 (en) | 2015-12-28 | 2017-07-06 | New York University | Device and method of restoring microbiota of newborns |
SI3313423T1 (sl) | 2016-03-04 | 2019-07-31 | 4D Pharma Plc | Sestavki, ki vsebujejo bakterijske seve Blautia za zdravljenje visceralne preobčutljivosti |
GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
EP3426269A4 (en) * | 2016-03-11 | 2019-10-16 | Evolve Biosystems Inc. | FOOD COMPOSITIONS FOR DEHUMIDIFICATION |
CA3025210A1 (en) | 2016-05-25 | 2017-11-30 | Mybiotics Pharma Ltd. | Composition and methods for microbiota therapy |
CA3029631A1 (en) | 2016-07-01 | 2018-01-04 | Evolve Biosystems, Inc. | Method for facilitating maturation of the mammalian immune system |
TWI802545B (zh) | 2016-07-13 | 2023-05-21 | 英商4D製藥有限公司 | 包含細菌菌株之組合物 |
CA3036365A1 (en) | 2016-09-13 | 2018-03-22 | Nestec S.A. | Fermented nutritional composition for cow's milk protein allergic subjects |
CN106267383A (zh) * | 2016-09-22 | 2017-01-04 | 南昌大学 | 一种用于恢复剖腹产新生儿共生微生物抹布的制备方法 |
GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
EP3592363A1 (en) * | 2017-03-08 | 2020-01-15 | N.V. Nutricia | Composition with non-digestible oligosaccharides for attenuating nasal epithelial inflammation |
EP3630136B1 (en) | 2017-05-22 | 2021-04-21 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
MA41708A (fr) | 2017-05-24 | 2020-04-08 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
IL292373A (en) | 2017-06-14 | 2022-06-01 | 4D Pharma Res Ltd | Preparations containing bacterial strains of the Megasphere genus and their use |
WO2018229188A1 (en) | 2017-06-14 | 2018-12-20 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
WO2019031961A1 (en) | 2017-08-11 | 2019-02-14 | N.V. Nutricia | OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION |
CN111372596A (zh) | 2017-08-30 | 2020-07-03 | 潘德勒姆治疗公司 | 用于治疗微生物组相关病症的方法和组合物 |
EP3723778A1 (en) * | 2017-12-11 | 2020-10-21 | N.V. Nutricia | Composition for use for treating delayed colonization by bifidobacterium after birth |
EP3782480A4 (en) * | 2018-03-29 | 2022-01-12 | Morinaga Milk Industry Co., Ltd. | NUTRITIONAL COMPOSITION, FOOD/BEVERAGE COMPOSITION USING THE NUTRITIONAL COMPOSITION AND MODIFIED MILK POWDER USING THE NUTRITIONAL COMPOSITION |
US20210161924A1 (en) * | 2018-06-19 | 2021-06-03 | Evolve Biosystems, Inc. | Novel oligosaccharides for use in prebiotic applications |
RU2729633C2 (ru) * | 2018-07-05 | 2020-08-11 | Общество С Ограниченной Ответственностью "Валента - Интеллект" | Биологически активная пищевая добавка для профилактики воспалительного заболевания кишечника и функциональных кишечных расстройств и способ ее получения |
EP3946392A4 (en) * | 2019-03-28 | 2022-12-07 | Mybiotics Pharma Ltd | PROBIOTIC BIOFILM COMPOSITIONS AND PROCESSES FOR THEIR PRODUCTION |
US10709744B1 (en) | 2019-03-28 | 2020-07-14 | Mybiotics Pharma Ltd. | Probiotic biofilm suppositories |
CN110882264B (zh) * | 2019-11-13 | 2021-03-26 | 青岛海洋生物医药研究院股份有限公司 | 一种天麻素和甘露糖醛酸寡糖的药物组合物及其用途 |
US20230149432A1 (en) * | 2020-04-03 | 2023-05-18 | Inner Mongolia Yili Industrial Group Co., Ltd. | Human Milk Oligosaccharides for Improving Resistance of Organism Against Staphylococcus Aureus Infection |
CN112933104B (zh) * | 2021-02-02 | 2021-12-14 | 陈玉松 | 核苷酸的新用途 |
WO2023118510A1 (en) | 2021-12-22 | 2023-06-29 | N.V. Nutricia | Mix of specific bifidobacterium species and specific non-digestible oligosaccharides |
WO2023216181A1 (en) | 2022-05-12 | 2023-11-16 | N.V. Nutricia | Improving micriobiota of infants born by caesarean section |
EP4299066A1 (en) * | 2022-06-27 | 2024-01-03 | Hipp & Co | Novel bifidobacterium breve strain |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2007350A6 (es) * | 1987-05-29 | 1989-06-16 | Ganadera Union Ind Agro | Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion. |
SU1743607A1 (ru) * | 1990-02-05 | 1992-06-30 | 2-й Московский государственный медицинский институт им.Н.И.Пирогова | Способ профилактики дисбактериоза кишечника у новорожденных детей |
US5472952A (en) * | 1993-03-18 | 1995-12-05 | Bristol-Myers Squibb Company | Partially hydrolyzed pectin in nutritional compositions |
IT1288119B1 (it) | 1996-06-28 | 1998-09-10 | Renata Maria Anna Ve Cavaliere | Composizioni dietetiche da utilizzare nell'alimentazione per via enterica |
NZ334021A (en) * | 1996-08-09 | 2001-01-26 | Mannatech Inc | Dietary supplement containing at least two saccharides being the building blocks of glycoproteins |
EP0856259B1 (en) * | 1996-12-23 | 1998-08-12 | SITIA-YOMO S.p.A. | Composition for feed use comprising lyophilized live lactic bacteria |
CN1099289C (zh) * | 1997-08-01 | 2003-01-22 | 北京东方百信生物技术有限公司 | 改善肠道生态平衡的微生物制剂及其工艺 |
DE19836339B4 (de) | 1998-08-11 | 2011-12-22 | N.V. Nutricia | Kohlenhydratmischung |
FR2782257B1 (fr) | 1998-08-13 | 2000-11-17 | Seb Sa | Joint indexe pour autocuiseur, et autocuiseur equipe d'un tel joint |
NL1010770C2 (nl) | 1998-12-09 | 2000-06-13 | Nutricia Nv | Preparaat dat oligosacchariden en probiotica bevat. |
JP3149403B2 (ja) * | 1999-03-02 | 2001-03-26 | 明治乳業株式会社 | ビフィズス菌によるオリゴ糖利用能改善剤 |
FR2795917B1 (fr) * | 1999-07-06 | 2001-08-31 | Gervais Danone Sa | Procede de preparation d'un produit lacte immunostimulant et ses applications |
DE19958985A1 (de) * | 1999-12-07 | 2001-06-13 | Nutricia Nv | Oligosaccharidmischung |
US6613549B2 (en) * | 2000-02-10 | 2003-09-02 | Urex Biotech, Inc. | Probiotic therapy for newborns |
DE10006989A1 (de) * | 2000-02-16 | 2001-08-23 | Nutricia Nv | Antiadhäsive Kohlenhydratmischung |
US20040143013A1 (en) * | 2000-02-28 | 2004-07-22 | Bristol-Myers Squibb Company | Use of docosahexaenoic acid and arachidonic acid enhancing the growth of preterm infants |
US6495599B2 (en) | 2000-04-13 | 2002-12-17 | Abbott Laboratories | Infant formulas containing long-chain polyunsaturated fatty acids and uses therof |
DE10057976B4 (de) * | 2000-11-22 | 2005-02-03 | Südzucker AG Mannheim/Ochsenfurt | Verfahren zur Herstellung von Pektinhydrolyseprodukten |
US6511696B2 (en) * | 2000-12-13 | 2003-01-28 | Novartis Nutrition Ag | Infant formula with free amino acids and nucleotides |
WO2002051264A2 (en) * | 2000-12-27 | 2002-07-04 | N.V. Nutricia | Nutritional composition with health promoting action containing oligo-saccharides |
FI109602B (fi) * | 2001-01-25 | 2002-09-13 | Valio Oy | Probioottiyhdistelmä |
US7223434B2 (en) | 2001-11-21 | 2007-05-29 | Gerber Products Company | Blended baby foods |
EP1364586A1 (en) | 2002-05-24 | 2003-11-26 | Nestec S.A. | Probiotics and oral tolerance |
EP1549158B1 (en) | 2002-10-10 | 2009-01-07 | Wyeth | Infant formula containing nucleotides |
BR0315209A (pt) | 2002-10-11 | 2005-08-16 | Wyeth Corp | Formulações nutritivas que contêm substâncias simbióticas |
WO2004067013A1 (en) * | 2003-01-24 | 2004-08-12 | Flora Technology Inc. | Compositions and methods for restoring bacterial flora |
AU2003303894A1 (en) | 2003-01-30 | 2004-08-30 | The Regents Of The University Of California | Inactivated probiotic bacteria and methods of use thereof |
US20050175759A1 (en) * | 2004-02-09 | 2005-08-11 | Atul Singhal | Newborn infant formulas and feeding methods |
FR2853908B1 (fr) | 2003-04-16 | 2005-06-03 | Gervais Danone Sa | Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant |
US20070031537A1 (en) | 2003-06-23 | 2007-02-08 | Marie-Cristene Secretin | Infant or follow-on formula |
CA2530437C (en) * | 2003-06-23 | 2011-11-15 | Nestec S.A. | Nutritional formula for optimal gut barrier function |
CN1566329A (zh) * | 2003-07-09 | 2005-01-19 | 喻超 | 一种延长5种双歧杆菌固体发酵物活菌保存期的制剂 |
WO2005051088A2 (en) * | 2003-11-12 | 2005-06-09 | Abbott Laboratories | Iron-containing human milk fortifier with improved antimicrobial properties |
CN1889856B (zh) | 2003-10-16 | 2011-03-02 | 雀巢技术公司 | 对抗化疗法和放射疗法的副作用的营养组合物 |
SI1733730T1 (sl) * | 2003-10-24 | 2008-12-31 | Nutricia Nv | Imunomodulirajoči oligosaharidi |
ES2314461T3 (es) * | 2003-10-24 | 2009-03-16 | N.V. Nutricia | Composicion simbiotica para bebes. |
CN1305383C (zh) * | 2003-11-03 | 2007-03-21 | 东北农业大学 | 一种含有双歧杆菌冻干粉的奶粉制品及其制备方法 |
EP1597978A1 (en) | 2004-05-17 | 2005-11-23 | Nutricia N.V. | Synergism of GOS and polyfructose |
US8252769B2 (en) * | 2004-06-22 | 2012-08-28 | N. V. Nutricia | Intestinal barrier integrity |
US7862808B2 (en) * | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
EP1634599A1 (en) | 2004-08-20 | 2006-03-15 | N.V. Nutricia | Iimmune stimulatory infant nutrition |
ATE361101T1 (de) * | 2004-08-24 | 2007-05-15 | Nutricia Nv | Nahrungszusammensetzung die unverdauliche oligosaccharide enthält |
AU2006215603A1 (en) | 2005-02-21 | 2006-08-24 | Nestec S.A. | Oligosaccharide mixture |
EP2805625B2 (en) | 2005-02-28 | 2022-11-23 | N.V. Nutricia | Nutritional composition with prebiotics and probiotics |
CA2604338A1 (en) | 2005-04-13 | 2006-10-19 | Nestec S.A. | Infant formula with probiotics |
US7303745B2 (en) * | 2005-04-15 | 2007-12-04 | Bristol-Myers Squibb Company | Method for preventing or treating the development of respiratory allergies |
EP1714660A1 (en) * | 2005-04-21 | 2006-10-25 | N.V. Nutricia | Uronic acid and probiotics |
RU2428056C2 (ru) | 2005-04-27 | 2011-09-10 | Н.В. Нютрисиа | Питание с липидами и неперевариваемыми сахаридами |
EP1776877A1 (en) | 2005-10-21 | 2007-04-25 | N.V. Nutricia | Method for stimulating the intestinal flora |
WO2010002241A1 (en) * | 2008-06-30 | 2010-01-07 | N.V. Nutricia | Nutritional composition for infants delivered via caesarean section |
-
2005
- 2005-10-21 EP EP05023029A patent/EP1776877A1/en not_active Withdrawn
-
2006
- 2006-10-06 US US12/091,011 patent/US8715769B2/en active Active
- 2006-10-06 DE DE602006008817T patent/DE602006008817D1/de active Active
- 2006-10-06 SG SG10201503970XA patent/SG10201503970XA/en unknown
- 2006-10-06 ES ES11178047.4T patent/ES2560291T3/es active Active
- 2006-10-06 NZ NZ567579A patent/NZ567579A/en unknown
- 2006-10-06 BR BRPI0617645-3A patent/BRPI0617645A2/pt not_active Application Discontinuation
- 2006-10-06 EP EP15181073.6A patent/EP2984943A1/en not_active Withdrawn
- 2006-10-06 PT PT111780474T patent/PT2407036E/pt unknown
- 2006-10-06 DK DK06799538T patent/DK1940247T3/da active
- 2006-10-06 ES ES06799537T patent/ES2350321T3/es active Active
- 2006-10-06 ES ES09161674.8T patent/ES2460590T3/es active Active
- 2006-10-06 CN CN201310722592.3A patent/CN103816173B/zh active Active
- 2006-10-06 EP EP06799536A patent/EP1940245B1/en not_active Not-in-force
- 2006-10-06 PL PL06799538T patent/PL1940247T3/pl unknown
- 2006-10-06 CN CN200680047651XA patent/CN101330838B/zh active Active
- 2006-10-06 CA CA2626615A patent/CA2626615C/en active Active
- 2006-10-06 DE DE602006016150T patent/DE602006016150D1/de active Active
- 2006-10-06 EP EP06799538A patent/EP1940247B1/en not_active Revoked
- 2006-10-06 HU HUE11178047A patent/HUE028348T2/en unknown
- 2006-10-06 CN CN201210414761.2A patent/CN102919663B/zh active Active
- 2006-10-06 EP EP06799537A patent/EP1940246B1/en not_active Revoked
- 2006-10-06 AT AT06799538T patent/ATE432620T1/de active
- 2006-10-06 AU AU2006304993A patent/AU2006304993A1/en not_active Abandoned
- 2006-10-06 DE DE602006007161T patent/DE602006007161D1/de active Active
- 2006-10-06 DK DK09161674.8T patent/DK2105055T3/da active
- 2006-10-06 DK DK11178047.4T patent/DK2407036T3/en active
- 2006-10-06 PT PT06799537T patent/PT1940246E/pt unknown
- 2006-10-06 DK DK06799537.3T patent/DK1940246T3/da active
- 2006-10-06 BR BRPI0617653A patent/BRPI0617653C1/pt not_active IP Right Cessation
- 2006-10-06 PT PT91616748T patent/PT2105055E/pt unknown
- 2006-10-06 PL PL11178047T patent/PL2407036T3/pl unknown
- 2006-10-06 RU RU2008120024/13A patent/RU2437581C2/ru not_active IP Right Cessation
- 2006-10-06 AU AU2006304992A patent/AU2006304992A1/en not_active Abandoned
- 2006-10-06 CN CN200680047835.6A patent/CN101360429B/zh not_active Expired - Fee Related
- 2006-10-06 US US12/091,050 patent/US20090221486A1/en not_active Abandoned
- 2006-10-06 PL PL09161674T patent/PL2105055T3/pl unknown
- 2006-10-06 AT AT06799536T patent/ATE440508T1/de not_active IP Right Cessation
- 2006-10-06 AT AT06799537T patent/ATE476877T1/de active
- 2006-10-06 CA CA2626636A patent/CA2626636C/en not_active Expired - Fee Related
- 2006-10-06 ES ES06799538T patent/ES2327781T3/es active Active
- 2006-10-06 NZ NZ616421A patent/NZ616421A/en unknown
- 2006-10-06 SG SG2011087186A patent/SG176521A1/en unknown
- 2006-10-06 PT PT06799538T patent/PT1940247E/pt unknown
- 2006-10-06 WO PCT/NL2006/050247 patent/WO2007046698A1/en active Application Filing
- 2006-10-06 PT PT06799536T patent/PT1940245E/pt unknown
- 2006-10-06 RU RU2008119992/13A patent/RU2424736C2/ru active
- 2006-10-06 MY MYPI20081206A patent/MY145999A/en unknown
- 2006-10-06 WO PCT/NL2006/050246 patent/WO2007046697A1/en active Application Filing
- 2006-10-06 WO PCT/NL2006/050248 patent/WO2007046699A2/en active Application Filing
- 2006-10-06 EP EP11178047.4A patent/EP2407036B1/en not_active Revoked
- 2006-10-06 PL PL06799537T patent/PL1940246T3/pl unknown
- 2006-10-06 JP JP2008536530A patent/JP2009512686A/ja active Pending
- 2006-10-06 MY MYPI20081205A patent/MY146454A/en unknown
- 2006-10-06 EP EP09161674.8A patent/EP2105055B1/en not_active Revoked
- 2006-10-06 NZ NZ599302A patent/NZ599302A/xx unknown
- 2006-10-06 CN CNA2006800473329A patent/CN101330837A/zh active Pending
- 2006-10-06 US US12/091,047 patent/US20090263537A1/en not_active Abandoned
- 2006-10-20 PL PL09011197T patent/PL2140771T3/pl unknown
- 2006-10-20 ES ES17205437T patent/ES2857732T3/es active Active
- 2006-10-20 CN CNA2006800354743A patent/CN101272701A/zh active Pending
- 2006-10-20 BR BRPI0617507-4A patent/BRPI0617507A2/pt not_active Application Discontinuation
- 2006-10-20 AR ARP060104605A patent/AR058132A1/es unknown
- 2006-10-20 EP EP06806443A patent/EP1940250B1/en not_active Revoked
- 2006-10-20 MY MYPI20081180A patent/MY145311A/en unknown
- 2006-10-20 PL PL13171226T patent/PL2638812T3/pl unknown
- 2006-10-20 CA CA2620821A patent/CA2620821C/en active Active
- 2006-10-20 AU AU2006303477A patent/AU2006303477A1/en not_active Abandoned
- 2006-10-20 PT PT131712267T patent/PT2638812T/pt unknown
- 2006-10-20 WO PCT/EP2006/010159 patent/WO2007045502A1/en active Application Filing
- 2006-10-20 RU RU2008115436/15A patent/RU2497535C2/ru active
- 2006-10-20 ES ES13171226.7T patent/ES2671914T3/es active Active
- 2006-10-20 CN CN201510171216.9A patent/CN105124565A/zh active Pending
- 2006-10-20 AR ARP060104593A patent/AR056145A1/es unknown
- 2006-10-20 DE DE602006009287T patent/DE602006009287D1/de active Active
- 2006-10-20 PT PT06806443T patent/PT1940250E/pt unknown
- 2006-10-20 TR TR2018/08654T patent/TR201808654T4/tr unknown
- 2006-10-20 CN CN201510170125.3A patent/CN104814442A/zh active Pending
- 2006-10-20 CN CN201310148476.5A patent/CN103230005B/zh active Active
- 2006-10-20 DK DK06806443T patent/DK1940250T3/da active
- 2006-10-20 DK DK13171226.7T patent/DK2638812T3/en active
- 2006-10-20 ES ES06806443T patent/ES2332064T3/es active Active
- 2006-10-20 AR ARP060104611A patent/AR058136A1/es unknown
- 2006-10-20 PL PL06806443T patent/PL1940250T3/pl unknown
- 2006-10-20 ES ES09011197.2T patent/ES2451020T3/es active Active
- 2006-10-20 PL PL17205437T patent/PL3326634T3/pl unknown
- 2006-10-20 AT AT06806443T patent/ATE442786T1/de active
- 2006-10-20 DK DK09011197.2T patent/DK2140771T3/en active
- 2006-10-20 EP EP09011197.2A patent/EP2140771B1/en not_active Revoked
- 2006-10-20 US US12/083,612 patent/US20090162323A1/en not_active Abandoned
- 2006-10-20 EP EP17205437.1A patent/EP3326634B1/en active Active
- 2006-10-20 AR ARP060104606A patent/AR058133A1/es not_active Application Discontinuation
- 2006-10-20 PT PT90111972T patent/PT2140771E/pt unknown
- 2006-10-20 HU HUE13171226A patent/HUE037858T2/hu unknown
- 2006-10-20 EP EP13171226.7A patent/EP2638812B1/en active Active
-
2008
- 2008-04-18 MY MYPI2012001490A patent/MY169058A/en unknown
-
2011
- 2011-09-08 RU RU2011137129/15A patent/RU2011137129A/ru unknown
-
2013
- 2013-05-29 RU RU2013125030A patent/RU2639490C2/ru active
- 2013-12-19 US US14/135,171 patent/US9107438B2/en active Active
-
2015
- 2015-07-30 US US14/813,845 patent/US9585416B2/en active Active
- 2015-09-04 US US14/846,120 patent/US20160058806A1/en not_active Abandoned
- 2015-12-17 US US14/973,166 patent/US9596876B2/en active Active
-
2017
- 2017-12-06 RU RU2017142555A patent/RU2762984C2/ru active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT2407036E (pt) | Resumo | |
GB2428259B (en) | System and method for forming downhole connections | |
EP2197535A4 (en) | DEVICE, SYSTEM AND METHOD FOR SELECTIVE STIMULATIONS | |
GB0526291D0 (en) | Therapeutic method | |
EP1979039A4 (en) | GASTROINTESTINAL DEVICE AND METHOD FOR TREATING DEPENDENCE | |
EP3700113C0 (en) | METHOD AND APPARATUS FOR ACKNOWLEDGMENT SIGNALING | |
ZA200904317B (en) | Improved method for making analgesics | |
ZA200809429B (en) | Method and means for treating inflammatory bowel disease | |
EP2192905A4 (en) | METHOD FOR SELECTIVE THERAPY OF DISEASE | |
EP2023074A4 (en) | EXPLOSION TREATMENT SYSTEM AND EXPLOSION TREATMENT PROCEDURE | |
EP2059211A4 (en) | SEXUAL PACING DEVICE | |
GB2473562B (en) | Apparatus and method for creating suggested pathways for helping pedestrians cross open spaces | |
EP2100140A4 (en) | METHOD FOR THE TREATMENT AND DIAGNOSIS OF FIBROTIC AND FIBROPROLIFERATIVE DISEASES | |
EP2008390A4 (en) | METHOD AND DEVICE FOR SELECTIVE CONFIRMATION | |
GB2444149B (en) | Well barrier apparatus and associated methods | |
GB0714319D0 (en) | Verification method | |
GB0607153D0 (en) | Therapeutic Method | |
EP1954188A4 (en) | ANTI-STRESS DRIVE METHOD | |
GB0701322D0 (en) | Flush-water treatment apparatus | |
GB0509930D0 (en) | Therapeutic method | |
GB0509932D0 (en) | Therapeutic method | |
GB0509929D0 (en) | Therapeutic method | |
GB0521562D0 (en) | Therapeutic method | |
GB0510213D0 (en) | Therapeutic method | |
GB0521540D0 (en) | Therapeutic method |